Skip to content
Preprint

Leveraging hologenomic data for phenotypic prediction: potential and pitfalls

Sep 2026 · 0 citations · 10 references
Mathematics

TL;DR

The results provide a structured framework to interrogate when and how integrating microbiota may enhance phenotypic prediction in breeding applications and show that the added value of hologenomic, compared to genomic prediction, is highly context dependent.

Abstract

The microbiota is increasingly recognized as an active component of host biology, influencing various host phenotypes. Advances in high-throughput sequencing and the emergence of the holobiont perspective have raised expectations regarding hologenomic-informed prediction. Yet, whether and under which conditions integrating microbiota and genomic data meaningfully improves phenotypic prediction remains unclear. The biological characteristics of the microbiota, including but not limited to transmission mechanisms, environmental effects and interactions with host genetics, complicate their integration into classical evaluation frameworks. In addition, microbiota datasets are high-dimensional, highly dispersed, sparse and compositional. Finally, analytical choices such as the taxonomic granularity considered for aggregation or the similarity matrix used in prediction models may impact downstream inference and prediction accuracy. Here we explore these challenges using a comprehensive set of transgenerational hologenomic simulations. By generating controlled and contrasted biological scenarios across a broad parameter space, we examine how microbiota granularity, variance structure and host modulation influence (i) the estimation of variance components and (ii) the accuracy of phenotypic prediction. We show that the added value of hologenomic, compared to genomic prediction, is highly context dependent. Our results provide a structured framework to interrogate when and how integrating microbiota may enhance phenotypic prediction in breeding applications.

View source

Similar papers

Review Sep 2026

Computational approaches to predicting xenobiotic metabolism by the human gut microbiota.

INTRODUCTION The human gut microbiota significantly influences drug pharmacokinetics and pharmacodynamics, driving interindividual variability in efficacy and toxicity. As experimental characterization of microbiome-mediated metabolism remains resource-intensive, computational prediction has emerged as an auxiliary str...

A. Kolodnitsky, A. Lagunin, V. Poroikov · 0 citations
#graph neural networks Review Open access Sep 2026

Integrating Metagenomics and Deep Learning for Accurate Microbial Species Differentiation

Accurate identification of microbial species is important for clinical diagnosis, environmental monitoring, and evaluations in agriculture and biotechnology. Conventional culture- and alignment-based metagenomic methods have several drawbacks, including inadequate reference databases, the cost of digital compilations,...

David Odiba, Faith Chidinma Terna, Osuyi Gerard Uyi et al. · 0 citations
Review Open access Sep 2026

From Prediction to Mechanism: Explainable AI for Plant–Microbiome Multi-Omics Integration and Biological Discovery

Predicting complex phenotypes from plant-microbiome multi-omics data has advanced significantly with machine learning and deep learning. However, traditional black-box models remain limited by their focus on predictive performance rather than mechanistic biological understanding. To bridge this gap, explainable artific...

L. Deng, Lei Liu, Yu Luo et al. · 0 citations
Review Open access Sep 2026

Methods to Address Compositional Data Challenges in Clinical Studies for the Safety Assessment of Human Microbiome Perturbations.

Advances in sequencing technologies have enabled increasingly detailed characterisation of the human microbiome in clinical studies, but interpretation of microbiome modulation which has relevance to health and disease characterisation or safety assessments remains methodologically challenging. Taxonomic profiles gener...

Aline Métris, Rui Guan, Antonis Ampatzoglou et al. · 0 citations
Open access Sep 2026

Mind the Gaps: Validating species presence under sparse genomic recovery in clinical metagenomics

1Clinical metagenomic sequencing is increasingly used to detect pathogens directly from clinical samples, but sparse and uneven genome recovery caused by low microbial biomass and stochastic fragment loss makes species-level validation difficult. Under these conditions, the same observed coverage may arise either from...

M. Behruznia, F. Silva-Toro, D. A. Márquez · 0 citations
Review Sep 2026

Integrating Transcriptomics and Metabolomics for Clinical Disease Detection: A Critical Review of Emerging Diagnostic Methodologies.

It is reported that no biomarker derived from integrated transcriptomic-metabolomic analysis has undergone analytical validation, entered regulatory qualification, or reached clinical implementation, and that where diagnostic performance is reported it belongs to a single-platform model rather than to the integrated si...

Kashyap N. Thummar, Sneha M. Nair, Foram K. Ravat et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.